ArticleFrontiers in pharmacology2018

Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer.

Zhen Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.